Učitavanje...
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
The first generation direct antiviral agents (DAAs) highlighted substantial prognosis improvement among liver transplant (LT) candidates and recipients with recurrent hepatitis C virus (HCV) infection. During 2014, second generation DAAs are associated with high sustained virological response rates...
Spremljeno u:
| Izdano u: | World J Hepatol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483543/ https://ncbi.nlm.nih.gov/pubmed/26140081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i12.1606 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|